The transaction forms part of NORD Holding’s buy-and-build strategy in the healthcare and nutraceuticals sector. Through the acquisition of EHF Production, 1Q Health Group aims to further expand its manufacturing capabilities and strengthen its position as a European contract development and manufacturing organization (CDMO) for nutritional supplements and pharmaceutical products.

Muzinich & Co. is an internationally active asset manager specializing in corporate and private credit investments.

Hogan Lovells advised Muzinich & Co. on all legal aspects of the financing. The team has extensive experience advising lenders and investors, and regularly supports complex national and cross-border financing transactions.

Hogan Lovells team for Muzinich & Co

Dr. Thomas Freund (Partner), Tiziana Daxenberger (Associate), Stefanie Grosch (Business Lawyer) (Banking & Finance, Munich);

Dr. Ingmar Dörr (Partner, Tax, Munich);

Dr. Malte Ingwersen (Counsel, Corporate M&A, Hamburg);

Wouter Jongen (Partner), Viney Akshaykumar Moerliesing (Senior Associate) (Banking & Finance, Amsterdam).